Platelet-rich plasma serotonin levels in chronic myeloproliferative disorders: Evaluation of diagnostic use and comparison with the neutrophil PRV-1 assay

British Journal of Haematology

Volumn 127, Issue 1, 2004, Pages 34-39

  Koch, Cody A ^a   Lasho, Terra L ^a   Tefferi, Ayalew ^a  

^a MAYO CLINIC   (United States)

Author keywords

Diagnosis; Myeloproliferative disorders; Polycythaemia; Polycythaemia rubra vera 1; Serotonin

Indexed keywords

BIOLOGICAL MARKER; CELL PROTEIN; PROTEIN PRV1; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYELOFIBROSIS; MYELOID METAPLASIA; MYELOPROLIFERATIVE DISORDER; NEUTROPHIL; POLYCYTHEMIA; POLYCYTHEMIA VERA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PRV 1 ASSAY; REAL TIME POLYMERASE CHAIN REACTION; SEROTONIN BLOOD LEVEL; THROMBOCYTE RICH PLASMA; THROMBOCYTHEMIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD PLATELETS; CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; ISOANTIGENS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MYELOPROLIFERATIVE DISORDERS; NEUTROPHILS; POLYCYTHEMIA; POLYCYTHEMIA VERA; PROSPECTIVE STUDIES; RECEPTORS, CELL SURFACE; SEROTONIN;

EID: 4944243980     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2004.05149.x     Document Type: Article

References (43)

1. Adams, T., Schutz, L. & Goldberg, L. (1974) Platelet function abnormalities in the myeloproliferative disorders. Scandinavian Journal of Haematology, 13, 215-224.
2. Anderson, G.M., Feibel, F.C. & Cohen, D.J. (1987) Determination of serotonin in whole blood, platelet-rich plasma, platelet-poor plasma and plasma ultrafiltrate. Life Sciences, 40, 1063-1070.
3. Balduini, C.L., Bertolino, G., Noris, P. & Piletta, G.C. (1991) Platelet aggregation in platelet-rich plasma and whole blood in 120 patients with myeloproliferative disorders. American Journal of Clinical Pathology, 95, 82-86.
4. Berger, S., Aledort, L.M., Gilbert, H.S., Hanson, J.P. & Wasserman, L.R. (1973) Abnormalities of platelet function in patients with polycythemia vera. Cancer Research, 33, 2683-2687.
5. Boneu, B., Nouvel, C., Sie, P., Caranobe, C., Combes, D., Laurent, G., Pris, J. & Bierme, R. (1980) Platelets in myeloproliferative disorders. I. A comparative evaluation with certain platelet function tests. Scandinavian Journal of Haematology, 25, 214-220.
6. Caranobe, C., Sie, P., Fernandez, F., Pris, J., Moatti, S. & Boneu, B. (1984) Abnormal platelet serotonin uptake and binding sites in myeloproliferative disorders. Thrombosis and Haemostasis, 51, 349-353.
7. Castaldi, P.A., Berndt, M.C., Booth, W., Gregory, C., Bull, H. & Greaves, M. (1982) Evidence for a platelet membrane defect in the myeloproliferative syndromes. Thrombosis Research, 27, 601-609.
8. Chauveau, J., Pert, V., Morel, A.M. & Delaage, M.A. (1991) Rapid and specific enzyme immunoassay of serotonin. Clinical Chemistry, 37, 1178-1184.
9. Cortellazzo, S., Viero, P., Buczko, W., Barbui, T. & de Gaetano, G. (1985) Platelet 5-hydroxytryptamine transport and storage in myeloproliferative disorders. Scandinavian Journal of Haematology, 34, 146-151.
10. Dewald, G.W., Wyatt, W.A., Juneau, A.L., Carlson, R.O., Zinsmeister, A.R., Jalal, S.M., Spurbeck, J.L. & Silver, R.T. (1998) Highly sensitive fluorescence in situ hybridization method to detect double BCR/ABL fusion and monitor response to therapy in chronic myeloid leukemia. Blood, 91, 3357-3365.
11. Dobo, I., Mossuz, P., Campos, L., Girodon, F., Allegraud, A., Latger-Cannard, V., Boiret, N., Pineau, D., Wunder, E., Zandecki, M., Praloran, V. & Hermouet, S. (2001) Comparison of four serum-free, cytokine-free media for analysis of endogenous erythroid colony growth in polycythemia vera and essential thrombocythemia. Hematology Journal, 2, 396-403.
12. Fabris, F., Randi, M.L., Casonato, A., Dal Bo Zanon, R., Bonvicini, P. & Girolami, A. (1984) Clinical significance of beta-thromboglobulin in patients with high platelet count. Acta Haematologica, 71, 32-38.
13. Gow, I.F., Corrie, J.E., Williams, B.C. & Edwards, C.R. (1987) Development and validation of an improved radioimmunoassay for serotonin in platelet-rich plasma. Clinica Chimica Acta, 162, 175-188.
14. Hergovich, N., Aigner, M., Eichler, H.G., Entlicher, J., Drucker, C. & Jilma, B. (2000) Paroxetine decreases platelet serotonin storage and platelet function in human beings. Clinical Pharmacology and Therapeutics, 68, 435-442.
15. Jackson, S., Ellis, P.M., Beeston, R. & Carter, J. (1992) Platelet imipramine binding is increased in essential thrombocythaemia. Blood Coagulation and Fibrinolysis, 3, 669-671.
16. Jaffe, E.S., Harris, N.L., Stein, H. & Vardiman, J.W. (eds) (2001) WHO Classification of Tumors: Tumors of the Hematopoietic and Lymphoid Tissues. IARC press, Lyon.
17. Jernej, B., Banovic, M., Cicin-Sain, L., Hranilovic, D., Balija, M., Oreskovic, D. & Folnegovic-Smalc, V. (2000) Physiological characteristics of platelet/circulatory serotonin: study on a large human population. Psychiatry Research, 94, 153-162.
18. Keating, J., Dratcu, L., Lader, M. & Sherwood, R.A. (1993) Measurement of plasma serotonin by high-performance liquid chromatography with electrochemical detection as an index of the in vivo activity of fluvoxamine. Journal of Chromatography. A, 615, 237-242.
19. Klippel, S., Strunck, E., Temerinac, S., Bench, A.J., Meinhardt, G., Mohr, U., Leichtel, R., Green, A.R., Greisshammer, M., Heimpel, H. & Pahl, H.L. (2003) Quantification of PRV-1 mRNA distinguishes polycythemia vera from secondary erythrocytosis. Blood, 102, 3569-3574.
20. Leoncini, G., Maresca, M., Buzzi, E., Piana, A. & Armani, U. (1990) Platelets of patients affected with essential thrombocythemia are abnormal in plasma membrane and adenine nucleotide content. European Journal of Haematology, 44, 116-120.
21. Majer, R.V., Dawe, A., Weir, P., Jones-Lecointe, A. & Green, P.J. (1991) Which tests are most useful in distinguishing between reactive thrombocytosis and the thrombocytosis of myeloproliferative disease? [comment]. Clinical and Laboratory Haematology, 13, 9-15.
22. Maurer-Spurej, E., Dyker, K., Gahl, W.A. & Devine, D.V. (2002) A novel immunocytochemical assay for the detection of serotonin in platelets. British Journal of Haematology, 116, 604-611.
23. Messinezy, M., Westwood, N.B., El-Hemaidi, I., Marsden, J.T., Sherwood, R.S. & Pearson, T.C. (2002) Serum erythropoietin values in erythrocytoses and in primary thrombocythaemia. British Journal of Haematology, 117, 47-53.
24. Moliterno, A.R., Hankins, W.D. & Spivak, J.L. (1998) Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera. New England Journal of Medicine, 338, 572-580.
25. Murphy, S. (1999) Diagnostic criteria and prognosis in polycythemia vera and essential thrombocythemia. Seminars in Hematology, 36, 9-13.
26. Murphy, S., Davis, J.L., Walsh, P.N. & Gardner, F.H. (1978) Template bleeding time and clinical hemorrhage in myeloproliferative disease. Archives of Internal Medicine, 138, 1251-1253.
27. Pareti, F.I., Gugliotta, L., Mannucci, L., Guarini, A. & Mannucci, P.M. (1982) Biochemical and metabolic aspects of platelet dysfunction in chronic myeloproliferative disorders. Thrombosis and Haemostasis, 47, 84-89.
28. Pearson, T.C. (2001) Evaluation of diagnostic criteria in polycythemia vera. Seminars in Hematology, 38, 21-24.
29. Raman, B.K., Van Slyck, E.J., Riddle, J., Sawdyk, M.A., Abraham, J.P. & Saeed, S.M. (1989) Platelet function and structure in myeloproliferative disease, myelodysplastic syndrome, and secondary thrombocytosis. American Journal of Clinical Pathology, 91, 647-655.
30. Schafer, A.I. (1984) Bleeding and thrombosis in the myeloproliferative disorders. Blood, 64, 1-12.
31. Schmitt, A., Jouault, H., Guichard, J., Wendling, F., Drouin, A. & Cramer, E.M. (2000) Pathologic interaction between megakaryocytes and polymorphonuclear leukocytes in myelofibrosis. Blood, 96, 1342-1347.
32. Shibano, M., Machii, T., Nishimori, Y., Nakamoto, I., Ueda, E., Masuhara, K. & Kitani, T. (1999) Assessment of alkaline phosphatase on the surface membrane of neutrophils by immunofluorescence. American Journal of Hematology, 60, 12-18.
33. Tanaka, C., Kuruma, I. & Kuramoto, A. (1967) Histochemical demonstration of 5-hydroxytryptamine in platelets and megakaryocytes. Blood, 30, 54-61.
34. Tefferi, A. (2003) Polycythemia vera: a comprehensive review and clinical recommendations. Mayo Clinic Proceedings, 78, 174-194.
35. Tefferi, A., Yoon, S.Y. & Li, C.Y. (2000) Immunohistochemical staining for megakaryocyte c-mpl may complement morphologic distinction between polycythemia vera and secondary erythrocytosis. Blood, 96, 771-772.
36. Tefferi, A., Lasho, T.L., Wolanskyj, A.P. & Mesa, R.A. (2004) Neutrophil PRV-1 expression across the chronic myeloproliferative disorders and in secondary or spurious polycythemia. Blood, 103, 3547-3548.
37. Thiele, J., Kvasnicka, H.M., Zankovich, R. & Diehl, V. (2001) The value of bone marrow histology in differentiating between early stage polycythemia vera and secondary (reactive) polycythemias. Haematologica, 86, 368-374.
38. Tranzer, J.P., Prada, M.D. & Pletscher, A. (1972) Storage of 5-hydroxytryptamine in megakaryocytes. Journal of Cell Biology, 52, 191-197.
39. Waddell, C.C., Brown, J.A. & Repinecz, Y.A. (1981) Abnormal platelet function in myeloproliferative disorders. Archives of Pathology and Laboratory Medicine, 105, 432-435.
40. Walsh, P.M., Murphy, S. & Barry, W.E. (1977) The role of platelets in the pathogenesis of thrombosis and hemorrhage in patients with thrombocytosis. Thrombosis and Haemostasis, 38, 1085-1096.
41. Yamamoto, K., Sekiguchi, E. & Takatani, O. (1984) Abnormalities of epinephrine-induced platelet aggregation and adenine nucleotides in myeloproliferative disorders. Thrombosis and Haemostasis, 52, 292-296.
42. Zahavi, J., Zahavi, M., Firsteter, E., Frish, B., Turleanu, R. & Rachmani, R. (1991) An abnormal pattern of multiple platelet function abnormalities and increased thromboxane generation in patients with primary thrombocytosis and thrombotic complications. European Journal of Haematology, 47, 326-332.
43. Zerbinati, P., Randi, M.L., Rossi, C., Soini, B. & Girolami, A. (1997) Two methods for intraplatelet serotonin evaluation - their use in thrombocytosis. Clinical and Applied Thrombosis Hemostasis, 3, 144-146.